Taro Pharmaceutical Industries (NYSE:TARO) will be issuing its quarterly earnings data after the market closes on Wednesday, May 22nd. Analysts expect the company to announce earnings of $2.26 per share for the quarter.
Taro Pharmaceutical Industries stock opened at $101.34 on Friday. Taro Pharmaceutical Industries has a 52 week low of $76.93 and a 52 week high of $121.23. The firm has a market cap of $4.02 billion, a PE ratio of 16.40 and a beta of 0.51.
Several analysts have recently commented on the stock. Zacks Investment Research cut shares of Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. TheStreet upgraded shares of Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research note on Friday, February 15th.
About Taro Pharmaceutical Industries
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories.
Recommended Story: Equity Income
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.